Ligandrol (LGD-4033)-Induced Liver Injury

We described a 32-year-old man who developed severe drug-induced liver injury after using Ligandrol (LGD-4033). The diagnosis was confirmed by a liver biopsy that showed cholestatic hepatitis with a mild portal, periportal, and perisinusoidal fibrosis. Ligandrol is a selective androgen receptor modu...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbara, Mary, Dhingra, Sadhna, Mindikoglu, Ayse L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304490/
https://www.ncbi.nlm.nih.gov/pubmed/32637435
http://dx.doi.org/10.14309/crj.0000000000000370
_version_ 1783548271237529600
author Barbara, Mary
Dhingra, Sadhna
Mindikoglu, Ayse L.
author_facet Barbara, Mary
Dhingra, Sadhna
Mindikoglu, Ayse L.
author_sort Barbara, Mary
collection PubMed
description We described a 32-year-old man who developed severe drug-induced liver injury after using Ligandrol (LGD-4033). The diagnosis was confirmed by a liver biopsy that showed cholestatic hepatitis with a mild portal, periportal, and perisinusoidal fibrosis. Ligandrol is a selective androgen receptor modulator that is available over the counter and via the internet.
format Online
Article
Text
id pubmed-7304490
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer
record_format MEDLINE/PubMed
spelling pubmed-73044902020-07-06 Ligandrol (LGD-4033)-Induced Liver Injury Barbara, Mary Dhingra, Sadhna Mindikoglu, Ayse L. ACG Case Rep J Case Report We described a 32-year-old man who developed severe drug-induced liver injury after using Ligandrol (LGD-4033). The diagnosis was confirmed by a liver biopsy that showed cholestatic hepatitis with a mild portal, periportal, and perisinusoidal fibrosis. Ligandrol is a selective androgen receptor modulator that is available over the counter and via the internet. Wolters Kluwer 2020-06-11 /pmc/articles/PMC7304490/ /pubmed/32637435 http://dx.doi.org/10.14309/crj.0000000000000370 Text en © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Case Report
Barbara, Mary
Dhingra, Sadhna
Mindikoglu, Ayse L.
Ligandrol (LGD-4033)-Induced Liver Injury
title Ligandrol (LGD-4033)-Induced Liver Injury
title_full Ligandrol (LGD-4033)-Induced Liver Injury
title_fullStr Ligandrol (LGD-4033)-Induced Liver Injury
title_full_unstemmed Ligandrol (LGD-4033)-Induced Liver Injury
title_short Ligandrol (LGD-4033)-Induced Liver Injury
title_sort ligandrol (lgd-4033)-induced liver injury
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304490/
https://www.ncbi.nlm.nih.gov/pubmed/32637435
http://dx.doi.org/10.14309/crj.0000000000000370
work_keys_str_mv AT barbaramary ligandrollgd4033inducedliverinjury
AT dhingrasadhna ligandrollgd4033inducedliverinjury
AT mindikogluaysel ligandrollgd4033inducedliverinjury

Ejemplares similares